GALAPAGOS (GLPG.AS) Financials
GLPG.AS Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 4.5 billion | 1.8 billion |
2023-06-30 | 4.5 billion | 1.9 billion |
2023-03-31 | 4.6 billion | 2.1 billion |
2022-12-31 | 4.7 billion | 2.2 billion |
GLPG.AS Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -122.0 million | ? |
2023-06-30 | -129.2 million | ? |
2023-03-31 | -99.2 million | ? |
2022-12-31 | -187.7 million | 37.4 million |
GLPG.AS Net Income
No data available :(
GLPG.AS Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | - | - | 14.1 million |
2023-06-30 | - | - | 15.4 million |
2023-03-31 | - | - | 16.0 million |
2022-12-31 | - | - | 21.9 million |
GLPG.AS Shares Outstanding
GLPG.AS Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 3.2 million | 100.3 million | 84.7 million | - |
2023-06-30 | 3.8 million | 108.4 million | 39.4 million | - |
2023-03-31 | 4.3 million | 103.5 million | 58.1 million | - |
2022-12-31 | 7.6 million | 151.0 million | 74.7 million | - |
GLPG.AS Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 120.0 million | 5.7 million |
2023-06-30 | 150.0 million | 4.3 million |
2023-03-31 | 178.9 million | 3.6 million |
2022-12-31 | 95.1 million | 4.1 million |
GLPG.AS
Price: €26.78
52 week price:
Earnings Per Share: -0.06 EUR
P/E Ratio: -15.65
Exchange: AMS
Sector: Healthcare
Industry: Biotechnology
Volume: 141215
Market Capitalization: 1.8 billion